Martínez-Baz Iván, Casado Itziar, Navascués Ana, Díaz-González Jorge, Aguinaga Aitziber, Barrado Laura, Delfrade Josu, Ezpeleta Carmen, Castilla Jesús
Instituto de Salud Pública de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
J Infect Dis. 2017 Mar 15;215(6):847-855. doi: 10.1093/infdis/jix055.
The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza A(H1N1)pdm09 vaccination from influenza seasons 2010-2011 to 2015-2016.
Patients attended with influenza-like illness were tested for influenza. Four periods with continued A(H1N1)pdm09 circulation were included in a test-negative design.
We enrolled 1278 cases and 2343 controls. As compared to individuals never vaccinated against influenza A(H1N1)pdm09, the highest effectiveness (66%; 95% confidence interval, 49%-78%) was observed in those vaccinated in the current season who had received 1-2 prior doses. The effectiveness was not statistically lower in individuals vaccinated in the current season only (52%) or in those without current vaccination and >2 prior doses (47%). However, the protection was lower in individuals vaccinated in the current season after >2 prior doses (38%; P = .009) or those currently unvaccinated with 1-2 prior doses (10%; P < .001). Current-season vaccination improved the effect in individuals with 1-2 prior doses and did not modify significantly the risk of influenza in individuals with >2 prior doses.
Current vaccination or several prior doses were needed for high protection. Despite the decreasing effect of repeated vaccination, current-season vaccination was not inferior to no current-season vaccination.
2009年甲型H1N1流感大流行(A[H1N1]pdm09)疫苗成分自2009年以来一直未变。我们评估了2010 - 2011年至2015 - 2016年流感季期间当前及既往接种甲型H1N1流感灭活疫苗的有效性。
对出现流感样疾病的患者进行流感检测。采用检测阴性设计纳入了甲型H1N1流感持续流行的四个时期。
我们纳入了1278例病例和2343例对照。与从未接种过甲型H1N1流感疫苗的个体相比,在当季接种且之前接种过1 - 2剂的个体中观察到最高有效性(66%;95%置信区间,49% - 78%)。仅在当季接种的个体(52%)或未进行当季接种但之前接种过超过2剂的个体(47%)中,有效性在统计学上没有更低。然而,在之前接种超过2剂后当季接种的个体(38%;P = 0.009)或当前未接种且之前接种过1 - 2剂的个体(10%;P < 0.001)中,保护作用较低。当季接种提高了之前接种过1 - 2剂个体的效果,并且对之前接种超过2剂个体的流感风险没有显著改变。
需要当前接种或几剂之前的接种才能获得高保护。尽管重复接种的效果在下降,但当季接种并不逊于未进行当季接种。